<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Dr. Lal Pathlabs Limited — News on 6ix</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd</link>
<description>Latest news and press releases for Dr. Lal Pathlabs Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 10:36:34 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/dr-lal-path-labs-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364c7678dffbe2df153b8e.webp</url>
<title>Dr. Lal Pathlabs Limited</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd</link>
</image>
<item>
<title>Press Release Apr 30 2026</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-apr-30-2026-24</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-apr-30-2026-24</guid>
<pubDate>Thu, 30 Apr 2026 10:36:34 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 30, 2026, titled "Press Release on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2026".</description>
</item>
<item>
<title>Press Release Jan 30 2026</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jan-30-2026-11</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jan-30-2026-11</guid>
<pubDate>Fri, 30 Jan 2026 18:41:48 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2026, titled "Press Release on the Un-audited Financial Results (Consolidated and Standalone) for the Quarter & Nine Months ended December 31, 2025".</description>
</item>
<item>
<title>Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/cardio-diagnostics-aimil-ltd-and-dr-lal-pathlabs-limited-partner-to-launch-the-precisionchdtm-test-in-india</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/cardio-diagnostics-aimil-ltd-and-dr-lal-pathlabs-limited-partner-to-launch-the-precisionchdtm-test-in-india</guid>
<pubDate>Wed, 07 Jan 2026 11:25:00 GMT</pubDate>
<description>CHICAGO, January 07, 2026--Cardio Diagnostics, Aimil Ltd., and Dr. Lal PathLabs announce strategic agreement to launch Cardio Diagnostics’ PrecisionCHD™ test in India.</description>
</item>
<item>
<title>Press Release Jan 06 2026</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jan-06-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jan-06-2026-1</guid>
<pubDate>Tue, 06 Jan 2026 14:05:29 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 06, 2026, titled "Dr. Lal PathLabs launches SOVAAKA a next-generation wellness centre blending science, technology, and personalized care".</description>
</item>
<item>
<title>Press Release Nov 26 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-nov-26-2025-4</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-nov-26-2025-4</guid>
<pubDate>Wed, 26 Nov 2025 15:05:21 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated November 26, 2025, titled "Dr. Lal PathLabs Strengthens Autoimmune Diagnosis with Indias First Comprehensive Complement Lab".</description>
</item>
<item>
<title>Press Release Oct 31 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-oct-31-2025-6</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-oct-31-2025-6</guid>
<pubDate>Fri, 31 Oct 2025 18:35:16 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated October 31, 2025, titled "Press Release on Un-audited Financial Results for Q2 H1 FY 26".</description>
</item>
<item>
<title>Press Release Aug 20 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-aug-20-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-aug-20-2025-1</guid>
<pubDate>Wed, 20 Aug 2025 14:32:51 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated August 20, 2025, titled "Dr. Lal PathLabs Pioneers AI Integration in Cancer Diagnosis in India".</description>
</item>
<item>
<title>Press Release Jul 31 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jul-31-2025-10</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jul-31-2025-10</guid>
<pubDate>Thu, 31 Jul 2025 17:45:11 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated July 31, 2025, titled "Press Release on unaudited financial results for the quarter ended June 30, 2025".</description>
</item>
<item>
<title>Press Release Jun 25 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jun-25-2025-3</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jun-25-2025-3</guid>
<pubDate>Wed, 25 Jun 2025 15:25:20 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated Jun 25, 2025, titled "Dr. Lal PathLabs strengthens its genomics capabilities with Illumina s NovaSeq X Series".</description>
</item>
<item>
<title>Press Release Apr 25 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-apr-25-2025-10</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-apr-25-2025-10</guid>
<pubDate>Fri, 25 Apr 2025 18:58:12 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 25, 2025, titled "Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2025".</description>
</item>
<item>
<title>Press Release Apr 15 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-apr-15-2025-4</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-apr-15-2025-4</guid>
<pubDate>Tue, 15 Apr 2025 14:41:45 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 15, 2025, titled "Dr. Lal PathLabs Becomes South Asia s First Diagnostic Chain to Launch Advanced Test for Amyloidosis".</description>
</item>
<item>
<title>Press Release Jan 30 2025</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jan-30-2025-13</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jan-30-2025-13</guid>
<pubDate>Thu, 30 Jan 2025 19:06:05 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2025, titled "Press Release on Financial Results for the quarter and nine months ended December 31, 2024".</description>
</item>
<item>
<title>Press Release Oct 23 2024</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-oct-23-2024-10</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-oct-23-2024-10</guid>
<pubDate>Wed, 23 Oct 2024 19:57:54 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated October 23, 2024, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2024".</description>
</item>
<item>
<title>Press Release Aug 07 2024</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-aug-07-2024-6</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-aug-07-2024-6</guid>
<pubDate>Wed, 07 Aug 2024 19:35:25 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated August 07, 2024, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024".</description>
</item>
<item>
<title>Press Release May 10 2024</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-may-10-2024-8</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-may-10-2024-8</guid>
<pubDate>Fri, 10 May 2024 18:11:21 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated May 10, 2024, titled "Press Release on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024".</description>
</item>
<item>
<title>Press Release Feb 01 2024</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-feb-01-2024-7</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-feb-01-2024-7</guid>
<pubDate>Thu, 01 Feb 2024 19:01:08 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated February 01, 2024, titled "Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2023".</description>
</item>
<item>
<title>Press Release Nov 02 2023</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-nov-02-2023-11</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-nov-02-2023-11</guid>
<pubDate>Thu, 02 Nov 2023 17:52:07 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated November 02, 2023, titled "Press release for quarter and half year ended September 30, 2023".</description>
</item>
<item>
<title>Press Release Jul 27 2023</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jul-27-2023-12</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-jul-27-2023-12</guid>
<pubDate>Thu, 27 Jul 2023 18:56:04 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated July 27, 2023, titled "Press Release on Un-Audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2023".</description>
</item>
<item>
<title>Press Release May 11 2023</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-may-11-2023-4</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-may-11-2023-4</guid>
<pubDate>Thu, 11 May 2023 18:23:56 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated May 11, 2023, titled "Press Release on Audited Financial Results for the Quarter and Financial Year ended March 31, 2023".</description>
</item>
<item>
<title>Press Release Feb 02 2023</title>
<link>https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-feb-02-2023-6</link>
<guid isPermaLink="true">https://6ix.com/company/dr-lal-path-labs-ltd/news/press-release-feb-02-2023-6</guid>
<pubDate>Thu, 02 Feb 2023 19:29:43 GMT</pubDate>
<description>Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated February 02, 2023, titled "Press Release for Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2022".</description>
</item>
</channel>
</rss>